Why Korea Is Now More Attractive To U.S. Biopharma

By Sungho Han, Ph.D.

By most measures, South Korea is an attractive market for pharma companies. The population, around 51 million, is roughly equal to California and North Carolina combined. Healthcare spending per capita is rising. Seniors — who account for higher pharmaceutical spending than other demographics — make up more than 16% of the population. Ranked by total spending, South Korea is among the top 15 markets for pharmaceutical sales.